FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma
FDA批准摘要：纳武利尤单抗联合伊匹木单抗治疗不可切除的恶性胸膜间皮瘤
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-1466
Nakajima, Erica C; Vellanki, Paz J; Larkins, Erin; Chatterjee, Somak; Mishra-Kalyani, Pallavi S; Bi, Youwei; Qosa, Hisham; Liu, Jiang; Zhao, Hong; Biable, Missiratch; Hotaki, Lauren Tesh; Shen, Yuan-Li; Pazdur, Richard; Beaver, Julia A; Singh, Harpreet; Donoghue, Martha
